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Insecticidal Activity of Bacillus thuringiensis Cry1Bh1 against Ostrinia
nubilalis (Hübner) (Lepidoptera: Crambidae) and Other Lepidopteran
Pests
Justin Lira, Jeff Beringer, Stephanie Burton, Samantha Griffin, Joel Sheets, Sek Yee Tan, Aaron Woosley, Sarah Worden,
Kenneth E. Narva
Dow AgroSciences, Indianapolis, Indiana, USA
Bacillus thuringiensis is an important source of insect resistance traits in commercial crops. In an effort to prolong B. thurin-
giensis trait durability, insect resistance management programs often include combinations of insecticidal proteins that are not
cross resistant or have demonstrable differences in their site of action as a means to mitigate the development of resistant insect
populations. In this report, we describe the activity spectrum of a novel B. thuringiensis Cry protein, Cry1Bh1, against several
lepidopteran pests, including laboratory-selected B. thuringiensis-resistant strains of Ostrinia nubilalis and Heliothis virescens
and progeny of field-evolved B. thuringiensis-resistant strains of Plutella xylostella and Spodoptera frugiperda. Cry1Bh1 is active
against susceptible and B. thuringiensis-resistant colonies of O. nubilalis, P. xylostella, and H. virescens in laboratory diet-based
assays, implying a lack of cross-resistance in these insects. However, Cry1Bh1 is not active against susceptible or Cry1F-resistant
S. frugiperda. Further, Cry1Bh1 does not compete with Cry1Fa or Cry1Ab for O. nubilalismidgut brush border membrane
binding sites. Cry1Bh1-expressing corn, while not completely resistant to insect damage, provided significantly better leaf pro-
tection against Cry1Fa-resistantO. nubilalis than did Cry1Fa-expressing hybrid corn. The lack of cross-resistance with Cry1Ab
and Cry1Fa along with independent membrane binding sites inO. nubilalismakes Cry1Bh1 a candidate to further optimize for
in-plant resistance to this pest.
Insect-resistant Bacillus thuringiensis-treated corn (Bt corn) is acommercial success due to the efficacy, convenience, and safety
of these products. Today, Bt corn is grown on more than 65% of
U.S. corn acreage (1). Ostrinia nubilalis is historically one of the
most damaging lepidopteran insect pests of corn throughout the
United States and Canada. Annual revenue loss due toO. nubilalis
resulting from reduced crop yield and expenditures for insect
management was previously estimated at U.S. $1 billion (2). At
present, economic losses due to O. nubilalis have been greatly
reduced due to widespread, successful use of Bt corn (3, 4).
Cry1Ab was the first B. thuringiensis trait commercialized for
control of O. nubilalis and continues to be used in a number of
transgenic corn events approved by the U.S. Environmental Pro-
tectionAgency (EPA) (5).B. thuringiensisCry1Fa protein inmaize
event TC1507 is another important tool for transgenic control of
lepidopteran pests due its broad spectrum of activity, which in-
cludesO. nubilalis and Spodoptera frugiperda (6–9). Other B. thu-
ringiensis proteins used for transgenic control ofO. nubilalis in the
United States include Cry1A.105 and Cry2Ab (5).
Despite the success of Bt corn, the long-term reliance on a
limited number of Cry proteins can lead to development of resis-
tant insect populations in the field. For example, Cry1Fa-resistant
populations of S. frugiperda were isolated from areas of Puerto
Rico where transgenic Cry1Famaize was extensively cultivated (8,
10).Ostrinia nubilalis resistance to Cry1Ab has also been detected
among individuals selected from field populations (11).
Combining two or more B. thuringiensis insecticidal proteins
that are not cross resistant and have independent sites of action is
one strategy to delay the development of resistant insect popula-
tions (12, 13). Previous studies demonstrated that Cry1B-type in-
secticidal toxins are active on a broad spectrum of lepidopteran
pests (for an overview, see reference 9). Cry1Ba1 (14) is the best-
studied Cry1B-type protein. Several reports indicated that
Cry1Ba is toxic to Cry1A-resistant colonies of Plutella xylostella
(15–20) and Heliothis virescens (21). Cry1Ba is also active against
Ostrinia nubilalis (22, 23) and does not share O. nubilalis midgut
binding sites with Cry1A proteins (22). Cry1Ba has been success-
fully expressed in transgenic maize to provide protection against
Diatraea saccharalis, Diatraea grandiosella, and Spodoptera fru-
giperda (24). In this report, we describe the characterization of a
new B. thuringiensis insecticidal protein (25). The primary aim of
this work was to assess the spectrum, potency, and potential resis-
tance management utility for Cry1Bh1.
MATERIALS AND METHODS
Preparation of B. thuringiensis genomic DNA. B. thuringiensis strain
PS46L was cultured in 4 ml of LB (Luria-Bertani) medium overnight at
28°C with shaking at 150 rpm and then centrifuged at 2,000 rpm for 20
min. The supernatant was removed and the cell pellet was resuspended
in the residual volume. Next, 150 l of the cell suspension was trans-
ferred to a 96-well plate. Total DNA was isolated by using the Qiagen
blood and tissue kit (catalog number 69582) according to the manu-
facturer’s protocol.
PCR and genome walking. An internal fragment of a putative cry1B
allele was amplified by PCR with cry1B degenerate primers (forward, GA
GGYASCCTTMTCTATACTATAGGG, and reverse, GGACTCGGTACC
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TGGAACATCC) using standard PCR conditions and the TaKaRa LA taq
kit (catalog number RR013B). Codes for degenerate base pairs were as
follows: m  A or C, y  C or T, and s  C or G. The resulting 1.2-kb
amplified DNA fragment was cloned into plasmid vector pCR2.1 (Invit-
rogen catalog number K4500-01) according to the manufacturer’s in-
structions. The amplification product was determined to contain a por-
tion of the cry1Bh1 gene. The complete Cry1Bh gene sequence was
elucidated using the Clontech GenomeWalker kit (catalog number
638904).
Cry1Bh1 protein expression and purification. Standard methods
were used to construct recombinant Pseudomonas fluorescens expression
plasmids containing a synthetic cry1Bh1 gene codon optimized for plant
expression (26). The expression plasmid was transformed by electropora-
tion into DC454 (a near-wild-type P. fluorescens strain having mutations
pyrF and lsc::lacIQI), recovered in SOC-Soy hydrolysate medium, and
plated onM9 glucose agar lacking uracil (27). Cry1Bh1 protein inclusion
bodies from recombinant P. fluorescens were prepared essentially as de-
scribed by Gao et al. (28).
Cry1Bh1 inclusion body preparations in 10mMCAPS (N-cyclohexyl-
3-aminopropanesulfonic acid, pH 10.0; Sigma-Aldrich Corporation)
were diluted to desired concentrations in the same buffer. Protein con-
centrations were estimated by gel electrophoresis using bovine serum al-
bumin (BSA; Sigma-Aldrich Corporation) to create a standard curve for
gel densitometry with a Bio-Rad imaging system (Fluor-S MultiImager
with Quantity One software, version 4.5.2).
Diet-based bioassay of Cry1Bh1. B. thuringiensis-resistant insect col-
onies used in this study are described in Table 1. Cry1A-resistant P. xylos-
tella (16) eggs were obtained from Benzon Research, Inc. The B. thuring-
iensis-resistant colonies of H. virescens and O. nubilalis were provided by
North Carolina State University and University of Nebraska—Lincoln,
respectively. The H. virescens YHD2 strain had mutations in both cad-
herin (29) and the ABC transporter (30) (F. Gould, personal communi-
cation).
Larval neonates of O. nubilalis, S. frugiperda, Cry1Fa-resistant S. fru-
giperda (8), Plutella xylostella (Linnaeus), B. thuringiensis HD-1-selected
P. xylostella (16),Helicoverpa zea (Boddie),Heliothis virescens (Fabricius),
and Diabrotica virgifera virgifera (LeConte) were tested with purified
Cry1Bh1 for insecticidal activity in diet overlay bioassays at a single dose
of 9,000 ng/cm2 (considered a high dose), except for O. nubilalis and H.
virescens, which were tested at 3,000 ng/cm2. Cry1Fa-resistant S. fru-
giperda andO. nubilalis, as well as CXC and YHD2 strains ofH. virescens,
weremaintained at theDowAgroSciences LLC insectary; eggs for all other
lepidopteran species were obtained from Benzon Research Inc. (Carlisle,
PA). Nondiapausing D. virgifera virgifera worms were obtained from
Crop Characteristics, Inc. (Farmington, MN).
Cry-resistant strains of H. virescens, CXC and YHD2, and Cry1Fa-
resistantO. nubilaliswere tested with Cry1Bh1 at 1,000 and 3,000 ng/cm2
in diet overlay bioassays, along with susceptible H. virescens and O. nubi-
lalis. Cry1Ac, Cry1Fa, and Cry2Aa were used as positive controls, while
water and 10 mM CAPS (pH 10.0) buffer were used as negative controls.
Susceptible and Cry1Fa-resistantO. nubilaliswere tested in a series of Cry
toxin amounts (0, 4.1, 12, 37, 111, 333, 1,000, and 3,000 ng/cm2) to gen-
erate dose-response data used to calculate specific activity values for mor-
tality, growth inhibition, and resistance ratio.
Bioassays were conducted in 128-well bioassay trays (C-D Interna-
tional, Pitman, NJ). A 40-l aliquot of protein sample was delivered onto
the surface of multispecies lepidopteran diet (Southland Products, Lake
Village, AR) in each well. The treated trays were air dried, and one indi-
vidual larva (24 to 48 h after eclosion) was deposited on the treated diet
surface. The infested wells were then sealed with adhesive sheets of clear
plastic vented to allow gas exchange (C-D International, Pitman, NJ).
Bioassay trays were held under controlled environmental conditions
(28°C,40% relative humidity, 16:8 h light/dark) for 5 days. For D. vir-
gifera virgifera, methods similar to the lepidopteran insect bioassays were
followed, except that a DowAgroSciences LLC proprietary rootwormdiet
was used and 80 to 100 l of aliquot solution was used to treat the diet
surface.
The total number of insects exposed to each protein sample, the num-
ber of dead insects, and theweight of surviving insects were recorded in all
insect bioassays. Larvae which weighed 0.1 mg were considered mori-
bund insects and were included in the percent mortality computation for
the dose-response study with the susceptible and Cry1Fa-resistant strains
ofO. nubilalis as well as the single-dose bioassays with theB. thuringiensis-
resistant H. virescens strains (CXC and YHD2) and Cry1Fa-resistant O.
nubilalis tested with Cry1Bh1 at 1,000 and 3,000 ng/cm2. Percent mortal-
ity and percent growth inhibition were calculated for each treatment.
Growth inhibition (GI) was calculated as follows: GI  1  (TWIT/
TNIT)/(TWIBC/TNIBC) 100, where TWIT is the total weight of insects
in the treatment, TNIT is the total number of insects in the treatment,
TWIBC is the total weight of insects in the buffer control, and TNIBC is
the total number of insects in the buffer control. Controlmortality did not
exceed 10%. Bioassays were replicated at least 4 times, with 8 lepidopteran
larvae or 17 D. virgifera virgifera larvae per replicate.
Initial insect screening at a single high dose, 3,000 or 9,000 ng/cm2, of
Cry1Bh1 and subsequent exposures of three resistant insect species to
various B. thuringiensis toxins were analyzed with a one-way analysis of
variance (ANOVA) and means separation by using the Tukey-Kramer
HSD test. With both susceptible and Cry1Fa-resistant strains of O. nubi-
lalis, the slope and growth inhibition concentration-response curves were
determined by using a nonlinear logistic 3-parameter model, and the ef-
fective concentrations required to cause 50% growth inhibition (GI50)
and 90% growth inhibition (GI90) were estimated. These analyses were
performed by using JMP Pro, version 9.0.3, software (SAS Institute Inc.,
Cary, NC). Probit analyses (31) of the pooled mortality data were con-
ducted using POLO-PC (LeOra Software) to estimate the 50% lethal
concentration (LC50), 90% lethal concentration (LC90), and slope of the
concentration-response curves. For O. nubilalis, a resistance ratio was
estimated by dividing the LC50 for the resistant strain by that for the
susceptible strain when their dose-response slopes were overlapping
based on the likelihood ratio test of parallelism tests (32).
Cry1Bh1 brush border membrane vesicle (BBMV) binding site in-
teractions. Purified trypsin-activated Cry1Ab toxin was iodinated using
Iodo-Beads (Pierce). Three Iodo-Beads were washed twice with 500 l of
phosphate-buffered saline (PBS; 20 mM sodium phosphate, 0.15MNaCl
TABLE 1 Cry toxin resistance levels of P. xylostella, S. frugiperda, O. nubilalis, and H. virescens
Insect species Strain Cry toxin resistance Reference
P. xylostella NO-QAGE Cry1Aa (	20,000-fold), Cry1Ab (	10,000-fold), Cry1Ac (	40,000-fold), Cry1Fa (	10,000-fold),
Cry1Ja (	2,000-fold); low resistance to Cry1Bb, Cry1Ca, Cry1Da, Cry2Aa, and Cry9Ca
16
S. frugiperda Cry1Fa-resistant SI Cry1Fa (	100-fold for growth inhibition rate) 8
O. nubilalis Cry1Fa resistant Cry1Fa (	3,000-fold) 42
H. virescens CXC Cry1Ac (50-fold), Cry1Ab (12-fold), Cry2Aa (52-fold), Cry1Aa (low level), Cry1B (low level),
Cry1C (low level)
44
H. virescens YHD2 Cry1Ac (10,000-fold); cross resistant to Cry1Aa (	2,000-fold) and Cry1Ab and Cry1Fa
(	3,500-fold); slightly cross resistant to Cry2A, Cry1B, and Cry1C
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[pH 7.5]) and placed into a 1.5-ml centrifuge tube behind lead shielding.
To this were added 100 l of PBS and 1 mCi of Na125I (17.4 Ci/mg;
Amersham). The components were allowed to react for 5 min at room
temperature, and then 2 g of highly pure trypsin-activated Cry1Ab pro-
tein in PBS was added to the solution and allowed to react for an addi-
tional 5 min. The reaction was terminated by removing the solution from
the Iodo-Beads and applying it to a PD-10 desalting column containing 20
mM CAPS, pH 10.5. Radiolabeled protein was collected by taking 0.2-ml
fractions. The radiopurity of the iodinated Cry proteins was determined
by SDS-PAGE and phosphorimaging the gel. Specific activity was deter-
mined to be 3.1 Ci/g of protein.
Standard radioiodination methods inactivate Cry1Fa, so we instead
radiolabeled fluorescein-5-maleimide with 125I and allowed this molecule
to attach toCry1Fa, which labels the single cysteine residue (C205) located
in the toxin core. Cry1Fa labeled by this protocol is biologically active
(33). Briefly, fluorescein-5-maleimide was dissolved to 10 mM (4.27 mg/
ml) in dimethyl sulfoxide (DMSO) and then diluted to 1 mM in PBS as
determined by its molar extinction coefficient of 68,000 M1cm1. A
total of 0.5 mCi of Na125I was added behind lead shielding to a 70-l
solution of PBS containing two Iodo-Beads (Pierce). The solution was
allowed tomix at room temperature for 5min, and then 10l of the 1mM
fluorescein-5-maleimide was added. The reactants were allowed to react
for 10 min and then removed from the Iodo-Beads. To the reacted solu-
tionwas added 2g of highly purified trypsin-activatedCry1Fa core toxin
in PBS. The protein was incubated with the iodinated fluorescein-5-
maleimide solution for 48 h at 4°C, and the reaction was stopped by
adding 2-mercaptoethanol to 14 mM. The reaction mixture was then
added to a Zebra spin column (Invitrogen) equilibrated in 20mMCAPS–
150 mM KCl (pH 9) and centrifuged at 1,500  g for 2 min to separate
nonreacted iodinated dye and 2-mercaptoethanol from the protein. The
125I-radiolabeled fluorescein-Cry1Fa was counted in a gamma counter to
determine its specific activity. Typically, specific activities of 1.1Ci/g of
Cry1Fa proteinwere obtained. The proteinwas also characterized by SDS-
PAGE and visualized by phosphorimaging to ensure that the radioactivity
measured was covalently associated with the Cry1Fa protein, which mi-
grated at a distance associated with 65-kDa proteins.
Reciprocal competition binding studies with labeled Cry1Bh1 were
not done.
BBMV preparation. Last-instarO. nubilalis larvae were starved over-
night and then dissected in the morning after chilling on ice for 15 min.
The midgut tissue was removed from the body cavity, leaving behind the
hindgut attached to the integument. Themidgutwas placed in 9 volume
of ice-cold homogenization buffer (300 mM mannitol, 5 mM EGTA, 17
mM Tris base [pH 7.5]) supplemented with protease inhibitor cocktail
(Sigma P-2714) diluted as recommended by the supplier. The tissue was
homogenized with 15 strokes of a glass tissue homogenizer. BBMVs were
prepared by the MgCl2 precipitation method of Wolfersberger (34).
Briefly, an equal volume of a 24mMMgCl2 solution in 300mMmannitol
wasmixed with themidgut homogenate, stirred for 5min, and allowed to
stand on ice for 15 min. The solution was centrifuged at 2,500 g for 15
min at 4°C. The supernatant was saved and the pellet suspended in the
original volume of 2-fold-diluted homogenization buffer and centrifuged
again. The two supernatants were combined and centrifuged at 27,000
g for 30 min at 4°C to form the BBMV fraction. The pellet was suspended
into BBMV storage buffer (10 mM HEPES, 130 mM KCl, 10% glycerol
[pH 7.4]) to a concentration of about 3 mg/ml of protein. Protein con-
centration was determined by using the Bradford method (35) with BSA
as the standard. Alkaline phosphatase (ALP) determination was made
prior to freezing the samples using the Sigma assay by following the man-
ufacturer’s instructions. The specific activity of this marker enzyme in the
BBMV fraction typically increased 7-fold compared to that found in the
midgut homogenate fraction. The BBMVs were aliquoted into 250-l
samples, flash frozen in liquid N2, and stored at80°C.
The binding of 125I-radiolabeled Cry1Ab or Cry1Fa to BBMVs pre-
pared from O. nubilalis was measured in triplicate by incubating 0.5 nM
125I-Cry1Ab or 2 nM 125I-Cry1Fa with 0.15 mg/ml of BBMV protein in a
total volume of 300 l in binding buffer (PBS plus 0.1% BSA) for 1 h at
28°C. The samples were centrifuged at full speed in a microcentrifuge
(16,000  g) for 8 min, and the supernatant was removed. The protein
pellet was washed twice with ice-cold binding buffer, and the bottom of
the microcentrifuge tube containing the pellet was cut out, placed in a
glass test tube, and counted in a gamma counter. Total radioactivity mea-
sured in the pellet in the absence of any competitor minus the amount of
radioactivitymeasured in the presence of 1,000 nMunlabeledCry1Abdue
to nonspecific binding was considered 100% specific binding. The
amount of total binding was measured in triplicate in the presence of
various concentrations of nonlabeled competing proteins and plotted.
Nonspecific binding represented 20.3 and 23.2% of total binding for 125I
Cry1Ab and 125I Cry1Fa, respectively.
Plant expression vector construction. Agrobacterium tumefaciens
standard binary vectors harboring expression cassettes encoding the acti-
vated form of Cry1Bh1 (amino acid residues 1 to 652) were engineered
using Gateway Technology (Invitrogen, Carlsbad, CA) and used in Agro-
bacterium-mediated plant transformation. Standard cloning methods
were used in the construction of entry vectors containing cry1Bh1 expres-
sion cassettes. Restriction endonucleases were obtained from New Eng-
land BioLabs (NEB; Ipswich, MA), and T4 DNA ligase (Invitrogen) was
used for DNA ligation. PCR amplification was performed using Phusion
high-fidelity DNA polymerase (NEB) and primers synthesized by Inte-
grated DNA Technologies Inc. (IDT; Coralville, IA). Gateway reactions
were performed using Gateway LR Clonase enzyme mix (Invitrogen) for
assembling entry and destination vectors. Plasmid preparations were per-
formed using either the NucleoSpin plasmid kit (Macherey-Nagel Inc.,
Bethlehem, PA) or the Plasmid Midi Kit (Qiagen) by following the in-
structions of the suppliers. DNA fragments were isolated using a
QIAquick gel extraction kit (Qiagen) after agarose Tris-acetate gel elec-
trophoresis.
Briefly, a synthetic cry1Bh1 gene optimized formaize codon usage was
obtained fromDNA2.0 (Menlo Park, CA) in plasmidDASDNA362. Plant
transformation vector construction was initiated with PCR amplification
of the maize-optimized cry1Bh1v3 gene from DASDNA362 with primers
DASDNA362 F2 andDASDNA362R2 to generate the 1,959-bp cry1Bh1v5
gene fragment encoding the insecticidal core protein. Primer sequences
were as follows: DASDNA362F2, CATTTTGACGGAGCTCTAGGTGAT
TAAGCTAACTATC, and DASDNA362R2, TGACGGAGCTCTAGGTG
ATTAAGCTAACTATCACCTTTCGAGGTCGTACTTCG.
The amplified fragment containing cry1Bh1v5 was digested with BbsI
and SacI and inserted into pDAB107604 digested with NcoI and SacI to
create entry vector pDAB109887 containing the ZmUbi1v2::cry1Bh1v5::
ZmLipv1 expression cassette flanked by attL1 and attL2 Gateway recom-
bination sites. The promoter in this expression cassette was the maize
ubiquitin promoter (36), and the 3= untranslated region was from the Zea
mays Viviparous-1 (Vp1) gene (GenBank accession number L35913).
pDAB109887 was recombined using Gateway technology with destina-
tion vector pDAB109805, which contained a proprietary selectable
marker cassette for haloxyfop resistance to create final binary vector
pDAB109890, coding for the approximate 65-kDa Cry1Bh1 insecticidal
core protein fragment. Constructs were transformed into maize via Agro-
bacterium-mediated transformation of immature embryos isolated from
the maize inbred line B104. The method used was similar to those pub-
lished by Ishida et al. and Frame et al. (37, 38).
Insect bioassay of Cry1Bh1-expressing corn lines. Five individual T1
generation corn plants per event, each hemizygous for the cry1Bh1 gene,
were evaluated at the V5 stage of development for resistance to feeding
damage by susceptible and Cry1Fa-resistant O. nubilalis. Events express-
ing yellow fluorescent protein (YFP) and a nontransformed isogenic corn
line (B104) were used as negative controls in the assay. A commercially
available Cry1Fa-expressing hybrid (event TC1507, Herculex I; HX1) was
used as a positive control in the assay. Cry1Bh1 protein expression was
performed via enzyme-linked immunosorbent assay (ELISA) (Envi-
Lira et al.
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roLogix, Portland,ME). Cry1Fa average protein expression in leaves of V3
to V5 plants grown in the greenhouse was used for comparison.
Thirty-two-well trays (C-D International, Pitman, NJ) were partially
filled with a 2% agar solution. Leaf sections from the 3rd- to 4th-collar
leaves, approximately 1 square inch in size, were taken from each plant,
and one was placed into each well of the 32-well trays. Three leaf pieces
were tested per event and per insect strain. Ten neonatal larvae (24 to 48 h
old) were added into each well using a paintbrush. Trays were sealed with
perforated sticky lids (C-D International), which allowed ventilation dur-
ing the test. Trays were placed in growth chambers at 28°C with 60%
relative humidity and 16:8 h of light/dark for 3 days. After the test, a visual
percent damage score was taken for each leaf piece. Percent leaf damage
for each event was averaged, and the leaf protection between the trans-
genic constructs was analyzed with ANOVA and mean separation using
the Tukey-Kramer honestly significant difference (HSD) test. Statistical
analyses were performed via JMP Pro 9.0.3 (SAS Institute Inc., NC).
Quantification of Cry1Bh1 protein expression levels in transgenic
maize. The amount of Cry1Bh1 in leaf material was determined by quan-
titative liquid chromatography coupled with tandem mass spectrometry
(LC-MS/MS) peptide analysis (39). Protein samples extracted frommaize
leaves in 25 mM ammonium bicarbonate plus 0.05% Tween 20 were
analyzed on an Agilent 1200 binary pump liquid chromatography system
and a QTRAP 5500 (model number 1024945-AA) using an Acquity ultra-
performance liquid chromatography (UPLC) BEH130 C18, 1.7-m, 2.1-
by 50-mm column. Two peptides were tracked (T37 [435.3m/z] and T24
[682.9 m/z]) for each sample. T37 was the most sensitive peptide; thus,
quantitation was based on the peptide transition 435.3/655.4.
Nucleotide sequence accession number. The sequence obtained for
Cry1Bh1 has been deposited in GenBank under accession number
ADT78693.
RESULTS
Sequence identity of Cry1Bh1. Cry1Bh1 shares 87% sequence
identity to its nearest neighbor, Cry1Bd2, and 72% sequence iden-
tity to Cry1Ba2 (25). Protein domain comparison to Cry1Bd2
revealed sequence identity scores of 98.7%, 75.5%, and 98.6% for
domains 1, 2, and 3, respectively. Domain 2 is associated with Cry
protein receptor binding (40, 41), and this domain contains most
of the sequence differences between Cry1Bh1 and Cry1Bd2. Fur-
ther, while Cry1Bh1 domain 3 is approximately 99% identical to
Cry1Bd2, it is interesting that the next nearest sequence identity
of approximately 81% is with domain 3 from Cry1Ac (data not
shown).
Insecticidal activity of Cry1Bh1 against susceptible and B.
thuringiensis-resistant insects. Cry1Bh1 insecticidal activity was
initially assayed at a dose of 9,000 or 3,000 ng/cm2 on several
lepidopteran pests. Cry1Bh1 caused 100%mortality on both sus-
ceptible andB. thuringiensisHD-1-resistant strains of P. xylostella,
as well as H. virescens (Table 2). Treatment of diet with 3,000
ng/cm2 ofCry1Bh1 resulted in 69% larvalmortality ofO. nubilalis.
Cry1Bh1 caused insignificant larval mortality of H. zea and was
not active on susceptible or Cry1Fa-resistant colonies of S. fru-
giperda. Cry1Bh1 also lacked activity on an important coleopteran
pest of corn, D. virgifera virgifera.
Additional bioassays were conducted at 1,000 ng/cm2 and
3,000 ng/cm2 on Cry1Fa-resistant O. nubilalis, Cry1Ac/Cry1Fa-
resistant H. virescens strain YHD2, and H. virescens strain CXC,
which is resistant to both Cry1Ac and Cry2A. These Cry-resistant
insect colonies were all susceptible to Cry1Bh1, as indicated by
high larval growth inhibition (	80%) at both toxin doses (Fig. 1).
However, Cry1Bh1 caused highermortality ofCry1Fa-resistantO.
nubilalis than of the twoCry-resistantH. virescens strains. At 3,000
ng/cm2, Cry1Bh1 caused growth inhibition and mortality of the
CXC strain comparable to those caused by Cry1Fa. Further, at
3,000 ng/cm2 the YHD2 strain was insensitive to either Cry1Ac or
Cry1Fa, whereas Cry1Bh1 exhibited significant toxicity against
this strain. Resistance of theH. virescens strains to the Cry proteins
used for selection, i.e., Cry1Ac or Cry2Aa, was confirmed in these
bioassays, as indicated by negligible larval mortality or growth
inhibition for these proteins. In fact, the CXC-resistant H. vire-
scens showed an increased growth rate when presented with
Cry2Aa, indicated by the negative growth inhibition values.
Next, the potency (LC50) of Cry1Bh1 against O. nubilalis and
Cry1Fa-resistant O. nubilalis was determined (Table 3). Cry1Bh1
protoxin was approximately 6.6-fold less potent than Cry1Fa pro-
toxin on susceptible O. nubilalis. Overlapping confidence inter-
vals of both lethal concentration and growth inhibition parame-
ters in the dose-response study indicated that Cry1Bh1 has similar
potencies against both the susceptible and Cry1Fa-resistant O.
nubilalis strains. Note that the Cry1Fa-resistantO. nubilalis strain
is more than 3,000-fold resistant to Cry1Fa (42).
Toxin binding studies.Radiolabeled Cry1Ab bound to BBMV
proteins from O. nubilalis larvae in a specific manner, with non-
specific binding representing 20.3% of total binding. Total bind-
ing was competed in a dose-dependent manner by the addition of
unlabeled Cry1Ab (Fig. 2). Total binding was reduced by 50% at
0.5 nM concentration of unlabeled Cry1Ab, the same concentra-
tion of radiolabeled Cry1Ab as used in the binding assay.
Cry1Bh1, on the other hand, had no effect on the total binding of
Cry1Ab to the BBMV proteins when added at concentrations as
high as 100 nM (1,000 times the concentration of the labeled li-
gand) and reduced the binding of 125I-Cry1Ab by only about 25%
at 300 nM. With 125I-Cry1Fa used as the radioligand, unlabeled
Cry1Fa competed for total binding in a concentration-dependent
manner; however, Cry1Bh1 did not compete with the binding of
125I-Cry1Fa even at 1,000 nM (Fig. 2), which is 500-fold higher
than the concentration of the radiolabeled substrate used in the
assay.We also used an alternative binding assay, whereO. nubilalis
BBMV protein bound with 125I-Cry1Fa was extensively washed,
solubilized, and separated by SDS-PAGE. In this assay format we
detected the presence of 125I-Cry1Fa bound to the BBMVby phos-
phorimaging the gel. In the presence of unlabeled Cry1Fa at 1,000
nM, the amount of radiolabeled Cry1Fa isolated bound to the
BBMV pellet was reduced to the level of nonspecific binding but
the presence of 1,000 nMCry1Bh1 did not compete with the bind-
ing of the 125I-Cry1Fa to the BBV protein (data not shown).
TABLE 2 Insecticidal activity spectrum of Cry1Bh1 protein tested at
9,000 ng/cm2 on diet overlay bioassays
Insect strain % mortalityb
Plutella xylostella 100*
B. thuringiensis HD-1-resistant P. xylostella 100*
Helicoverpa zea 3ns
Ostrinia nubilalisza 69*
Heliothis virescensa 100*
Spodoptera frugiperda 0ns
Cry1Fa resistant S. frugiperda 0ns
Diabrotica virgifera virgiferaa 7ns
a O. nubilalis and H. virescens were tested at 3,000 ng/cm2, and D. virgifera virgifera was
tested at 400 g/cm2.
b Values with asterisks are significantly different from the buffer control, while a
superscript “ns” indicates a comparable response according to Fisher protected
ANOVA (P 0.05).
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Protection of Cry1Bh1-containing corn to damage byO. nu-
bilalis. Transgenic corn lines expressing Cry1Bh1 demonstrated a
range of protection to leaf damage by susceptible (Fig. 3A) and
Cry1Fa-resistant (Fig. 3B) O. nubilalis. For susceptible O. nubila-
lis, the activated form of Cry1Bh1 expressed in transgenic maize
events provided significant leaf protection compared to negative
controls. Against Cry1Fa-resistantO. nubilalis, leaf protectionwas
also significantly higher inmaize expressing Cry1Bh than inmaize
expressing Cry1Fa. Leaf damage to the experimental Cry1Bh1
events by susceptibleO. nubilaliswas greater than the commercial
standard (Herculex I).
Protein expression across Cry1Bh1 events ranged from ap-
proximately 10 to 30 ng/cm2 of protein except for event 2, which
provided elevated protein expression (75 ng/cm2). However,
event 2 did not exhibit significantly less leaf damage than did the
rest of the Cry1Bh1 events. Across events other than event 2,
Cry1Bh1 protein expression levels were approximately 25 to 75%
of the level of Cry1Fa ( 40 ng/cm2) in Herculex I. Cry1Bh1
FIG 1 Mean percent growth inhibition (dark gray bars) and mortality (light gray bars) of the B. thuringiensis-resistant H. virescens strains CXC and YHD2 and
Cry1Fa-resistant O. nubilalis when fed with Cry1Fa, Cry2Aa, Cry1Ac, and Cry1Bh1 toxins at 1,000 and 3,000 ng/cm2. Bars followed by the same letters are not
significantly different according to Fisher protected ANOVA and the Tukey-Kramer HSD test (P	 0.05). Lowercase a, b, and c indicate mean percent growth
inhibition, while A and B indicate mean percent mortality (4 replications, n 8).
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events provided less leaf protection (approximately 30% insect
feeding damage) against O. nubilalis than for Herculex 1 (5%
insect feeding damage).
DISCUSSION
As a class, Cry1B-type B. thuringiensis insecticidal proteins are
active against a broad spectrum of lepidopteran pests. Cry1B pro-
teins show little to no cross-resistance with other Cry1 proteins
when tested onCry1A-resistant colonies of some important insect
pests, e.g., P. xylostella and H. virescens (15–21, 43). Further, the
most studied toxin of this family, Cry1Ba, was shown to recognize
different midgut binding sites than Cry1A toxins in P. xylostella
(15) andO. nubilalis (22) as well asD. saccharalis,D. grandiosella,
and S. frugiperda (24).
The primary objective of the work presented here was to deter-
mine whether a new Cry1B family member, Cry1Bh1, has cross-
resistance and competitive binding properties compatible with
other Cry1 proteins for insect resistance management (IRM) in
economically important lepidopteran pests. First, in laboratory
bioassays we examined the spectrum of Cry1Bh1 lepidopteran
insecticidal activity, including four insect colonies resistant to
Cry1 proteins. Results demonstrated that Cry1Bh1 potencies were
statistically similar for both Cry1Fa-susceptible and Cry1Fa-resis-
tant O. nubilalis, with a resistance ratio of approximately 0.6 to
0.7. In comparison, the Cry1Fa-resistant O. nubilalis strain was
3,000-fold resistant to Cry1Fa (42). This suggests that Cry1Bh1
and Cry1Fa are not cross resistant inO. nubilalis. We also demon-
strated that Cry1Bh1 has activity on Cry1-resistant P. xylostella
(selected on B. thuringiensis strain HD-1), H. virescens strain
YDH2 (Cry1Ac resistant), and H. virescens strain CXC (Cry1Ac
resistant and Cry2A resistant). The absence, or very low levels, of
cross-resistance for Cry1Bh1 on these insect colonies is consistent
with the results for other Cry1B-type proteins tested previously
(16, 21, 44).
The susceptibility of the B. thuringiensis-resistant insect strains
to Cry1Bh1 suggests a different site or mechanism of action com-
pared to Cry1Ac in P. xylostellaNO-QAGE and to both Cry1Ac or
Cry2Aa proteins in H. virescens YHD2 and CXC colonies. Muta-
tions in membrane-bound protein receptors are implicated as
Cry1A resistance determinants in these colonies. An ABC trans-
porter was reported to be involved in Cry1Ac resistance in P.
xylostella NO-QAGE (45). Both cadherin and ABC transporters
have been implicated in resistance toCry1Ac inH. virescensYHD2
(29, 30). It follows that the Cry1Bh1 membrane interactions are
distinct from these characterized resistance determinants. In ad-
dition, reduced membrane-bound alkaline phosphatase (ALP)
protein is correlated with resistance phenotypes for both YHD2
(46) and CXC strains of H. virescens (47), but reduction in ALP
levels is apparently independent of the resistance mechanism in
these colonies.
To further assess whether Cry1Bh1 is compatible in combina-
tion with Cry1Ab or Cry1Fa for resistance management of O.
nubilalis, we studied the binding site interactions of this protein
on midgut BBMVs. Our results indicated that Cry1Bh1 does not
compete with the binding of either Cry1Ab or Cry1Fa in O. nubi-
lalis BBMVs. This suggests differences in binding site interactions
for Cry1Bh1 compared to Cry1Ab or Cry1Fa in O. nubilalis that
TABLE 3 Susceptibilities of Ostrinia nubilalis and Cry1Fa-resistant O. nubilalis neonates exposed to the Bacillus thuringiensis Cry1Bh1 and Cry1Fa
protoxins measured by mortality and growth inhibition
Insect Protein Dose response
50% estimation
(95% FL)a 90% estimation (95% FL)a Nb
Slope
(SE) 
2c r2d df
O. nubilalis Cry1Fa Lethality (LCe) 253.2 (185.7–335.4) 1,004.9 (707.6–1,683.6) 216 2.1 (0.3) 2.1 3
Growth inhibition (ECf) 2.5 (1.3–4.9) 33.8 (6.3–182.5) 336 0.9 (0.4) 0.6193 21
Cry1Bh Lethality (LC) 1,679.7 (1,239.0–2,493.6) 6,552.1 (3,936.4–17,158.0) 160 2.2 (0.4) 0.4 2
Growth inhibition (EC) 293.7 (215.3–400.6) 1,658.0 (1,009.5–2,723.0) 224 1.0 (0.2) 0.9788 25
Cry1Fa-resistant
O. nubilalis
Cry1Bh Lethality (LC) 1,008.1 (766.2–1,355.2) 3,397.6 (2,316.2–6,299.2) 192 2.4 (0.4) 2.7 3
Growth inhibition (EC) 216.3 (170.4–274.7) 1,136.2 (718.2–1,797.7) 159 1.2 (0.2) 0.9629 14
a ng of Cry toxin/cm2 of treated artificial diet surface, with 95% fiducial limits (FL) in parentheses. Mortality was calculated by probit analysis, and growth inhibition relative to
untreated control was calculated by nonlinear regression fitted to a logistic 3-parameter model.
b Total number of larvae tested in bioassay.
c 
2 values from the goodness-of-fit test indicate a significant (P 0.05) fit of the probit model for lethal-concentration statistics.
d r2 of1 from the nonlinear regression tests indicate significant fit to a logistic 3-parameter model for growth inhibition statistics.
e LC, lethal concentration.
f EC, effective concentration.
FIG 2 Competition binding of 125I-Cry1Ab and 125I Cry1Fa with Cry1Ab or
Cry1Bh to BBMVs prepared from Ostrinia nubilalis. Circles, Cry1Ab com-
peted against 0.1 nM 125I Cry1Ab; squares, Cry1Bh competed against 0.1 nM
Cry1Ab; triangles, Cry1Fa competed against 2 nM 125I Cry1Fa; diamonds,
Cry1Bh competed against 2 nM 125I Cry1Fa.
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could be useful for mitigation of receptor-mediated mechanisms
of resistance. That said, the resistancemechanism for the Cry1Ab-
or Cry1Fa-resistant colonies tested in this study is unknown, and
as yet, there is no evidence for binding site-mediated resistance in
either colony (48, 49).
Finally, we demonstrated that transgenic corn events express-
ing the Cry1Bh1 toxic core fragment had much less foliar damage
caused by Cry1Fa-susceptible or Cry1Fa-resistant O. nubilalis
than with nontransgenic isolines. The Cry1Bh1 level of leaf pro-
tection against susceptibleO. nubilaliswas, however, less than that
of the commercial standard, Herculex I. The less than acceptable
levels of insect control, compared to the commercialized corn
hybrid, could be the result of lower expression levels combined
with lower inherent potency of Cry1Bh1 than for Cry1Fa.
In conclusion, the results presented here suggest that Cry1Bh1
has biological properties that make it interesting to consider as a
candidate for gene pyramids when combined with Cry1 proteins.
However, further work is needed to optimize Cry1Bh1 insect re-
sistance trait efficacy to control against Cry1Ab or Cry1Fa resis-
tance in O. nubilalis.
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